MCE - Delayed Quote EUR

Prim, S.A. (PRM.MC)

10.25 +0.25 (+2.50%)
At close: April 26 at 5:35 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
216,510.63
216,510.63
197,245.07
168,512.43
147,323.95
Cost of Revenue
109,675.88
109,675.88
102,686.67
85,427.78
72,868.34
Gross Profit
106,834.74
106,834.74
94,558.41
83,084.65
74,455.61
Operating Expense
90,947.80
90,947.80
83,001.20
65,922.95
60,172.11
Operating Income
15,886.94
15,886.94
11,557.21
17,161.70
14,283.49
Net Non Operating Interest Income Expense
-540.36
-540.36
575.41
738.65
711.03
Pretax Income
17,025.51
17,025.51
10,873.55
23,058.72
9,341.71
Tax Provision
4,352.94
4,352.94
2,482.29
5,636.13
2,424.41
Net Income Common Stockholders
12,672.57
12,672.57
8,391.27
17,422.59
6,917.30
Diluted NI Available to Com Stockholders
12,672.57
12,672.57
8,391.27
17,422.59
6,917.30
Basic EPS
0.56
0.74
0.49
1.01
0.40
Diluted EPS
0.56
0.74
0.49
1.01
0.40
Basic Average Shares
17,024.04
17,010.25
17,059.60
17,220.20
17,321.52
Diluted Average Shares
17,024.04
17,010.25
17,059.60
17,220.20
17,321.52
Total Operating Income as Reported
16,012.38
16,012.38
9,353.99
17,339.49
13,913.56
Rent Expense Supplemental
1,413.87
1,413.87
1,425.00
650.19
660.63
Total Expenses
200,623.69
200,623.69
185,687.87
151,350.73
133,040.45
Net Income from Continuing & Discontinued Operation
12,672.57
12,672.57
8,391.27
17,422.59
6,917.30
Normalized Income
11,533.95
11,533.95
9,799.22
13,554.53
11,195.64
Interest Income
429.86
429.86
974.82
956.47
888.01
Interest Expense
826.37
826.37
280.71
134.79
124.36
Net Interest Income
-540.36
-540.36
575.41
738.65
711.03
EBIT
17,851.89
17,851.89
11,154.26
23,193.50
9,466.07
EBITDA
27,894.52
27,894.52
19,531.51
30,092.29
15,368.59
Reconciled Cost of Revenue
109,675.88
109,675.88
102,686.67
85,427.78
72,868.34
Reconciled Depreciation
10,042.63
10,042.63
8,377.25
6,898.79
5,902.52
Net Income from Continuing Operation Net Minority Interest
12,672.57
12,672.57
8,391.27
17,422.59
6,917.30
Total Unusual Items Excluding Goodwill
1,529.78
1,529.78
-1,824.48
5,119.19
-5,777.63
Total Unusual Items
1,529.78
1,529.78
-1,824.48
5,119.19
-5,777.63
Normalized EBITDA
26,364.74
26,364.74
21,355.99
24,973.11
21,146.22
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
391.17
391.17
-416.53
1,251.13
-1,499.29
12/31/2020 - 4/1/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DXR Daxor Corporation
9.65
-0.62%
 
BIOT.ST Biotage AB (publ)
165.50
+1.47%
 
GMVDF G Medical Innovations Holdings Ltd
0.0200
+17.65%
 
ALIF-B.ST AddLife AB (publ)
98.65
+2.02%
 
TECN.SW Tecan Group AG
332.60
+1.65%
 
BONEX.ST Bonesupport Holding AB (publ)
232.00
-2.36%
 
ALC.SW Alcon Inc.
72.00
+0.61%
 
CTEC.L ConvaTec Group PLC
257.80
-6.46%
 
RVP Retractable Technologies, Inc.
1.0750
+1.42%
 
STMN.SW Straumann Holding AG
138.10
+3.41%